Surgalign Holdings Past Earnings Performance
Past criteria checks 0/6
Surgalign Holdings's earnings have been declining at an average annual rate of -9.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 27.9% per year.
Key information
-9.6%
Earnings growth rate
0.08%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | -27.9% |
Return on equity | n/a |
Net Margin | -64.6% |
Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Surgalign stock rises 7% after receiving FDA clearance of Cortera spinal fixation system
Aug 24Surgalign revenue of $20.62M misses by $0.51M, reconfirms full-year revenue
Aug 09Surgalign Holdings - A Future Of Digital Surgery
Dec 21Sizing Up Surgalign
Sep 23Surgalign Holdings: Insiders Are Buying
Aug 28Surgalign Holdings: Pinocchio Has A Happy Ending
Aug 10Surgalign Holdings: A Marketing Ploy
Jun 29Surgalign reports inducement grants under Nasdaq listing rule
Jun 04Have Insiders Been Buying Surgalign Holdings, Inc. (NASDAQ:SRGA) Shares?
Mar 08Surgalign Holdings : Strong Upside Potential
Jan 11Revenue & Expenses Breakdown
How Surgalign Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 78 | -50 | 92 | 14 |
31 Dec 22 | 82 | -55 | 96 | 16 |
30 Sep 22 | 83 | -62 | 99 | 17 |
30 Jun 22 | 84 | -61 | 103 | 16 |
31 Mar 22 | 88 | -66 | 104 | 15 |
31 Dec 21 | 91 | -81 | 104 | 14 |
30 Sep 21 | 95 | -152 | 107 | 11 |
30 Jun 21 | 102 | -171 | 107 | 10 |
31 Mar 21 | 98 | -185 | 113 | 11 |
31 Dec 20 | 102 | -194 | 124 | 12 |
30 Sep 20 | 107 | -275 | 137 | 14 |
30 Jun 20 | 108 | -266 | 144 | 16 |
31 Mar 20 | 75 | -264 | 140 | 17 |
31 Dec 19 | 117 | -249 | 135 | 17 |
30 Sep 19 | 157 | -49 | 128 | 17 |
30 Jun 19 | 197 | -29 | 123 | 16 |
31 Mar 19 | 280 | -13 | 123 | 15 |
31 Dec 18 | 92 | -52 | 98 | 14 |
30 Sep 18 | 280 | -14 | 116 | 13 |
30 Jun 18 | 278 | 0 | 114 | 13 |
31 Mar 18 | 280 | 3 | 114 | 13 |
31 Dec 17 | 280 | 3 | 115 | 13 |
30 Sep 17 | 280 | -1 | 116 | 14 |
30 Jun 17 | 280 | -22 | 117 | 15 |
31 Mar 17 | 275 | -22 | 118 | 16 |
31 Dec 16 | 276 | -17 | 117 | 16 |
30 Sep 16 | 278 | -3 | 115 | 16 |
30 Jun 16 | 278 | 4 | 111 | 16 |
31 Mar 16 | 282 | 10 | 108 | 16 |
31 Dec 15 | 282 | 12 | 107 | 15 |
30 Sep 15 | 277 | 8 | 108 | 16 |
30 Jun 15 | 276 | 7 | 109 | 16 |
31 Mar 15 | 270 | 6 | 109 | 15 |
31 Dec 14 | 263 | 0 | 108 | 16 |
30 Sep 14 | 252 | -9 | 105 | 15 |
30 Jun 14 | 242 | -19 | 103 | 16 |
31 Mar 14 | 218 | -24 | 91 | 16 |
31 Dec 13 | 198 | -19 | 82 | 15 |
30 Sep 13 | 182 | -8 | 71 | 14 |
30 Jun 13 | 172 | 4 | 60 | 13 |
31 Mar 13 | 175 | 8 | 59 | 13 |
31 Dec 12 | 178 | 8 | 58 | 12 |
Quality Earnings: SRGA.Q is currently unprofitable.
Growing Profit Margin: SRGA.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SRGA.Q is unprofitable, and losses have increased over the past 5 years at a rate of 9.6% per year.
Accelerating Growth: Unable to compare SRGA.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SRGA.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: SRGA.Q's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.